DIA423.97-0.97 -0.23%
SPX5,939.30-31.51 -0.53%
IXIC19,298.45-162.04 -0.83%

Why Credo Technology Group Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket

Benzinga·06/03/2025 10:30:29
Listen to the news

Shares of Credo Technology Group Holding Ltd (NASDAQ:CRDO) rose sharply in today's pre-market trading following upbeat quarterly results.

The company reported fourth-quarter revenue of $170.03 million, beating analyst estimates of $162.96 million. The connectivity solutions company reported fourth-quarter adjusted earnings of 35 cents per share, beating analyst estimates of 28 cents per share, according to Benzinga Pro.

Credo Technology Group shares jumped 14.3% to $71.60 in the pre-market trading session.

Here are some other stocks moving in pre-market trading.

Gainers

  • NewGenIvf Group Limited (NASDAQ:NIVF) shares jumped 192.4% to $5.03 in pre-market trading. NewGenIvf Group recently announced a $30 million investment in Solana Digital Asset staking.
  • Shineco, Inc. (NASDAQ:SISI) surged 36.4% to $0.5878 in pre-market trading after the company announced that it will raised $13.5 million through the sale of 18 million common shares at $0.75 each to non-US investors.
  • Revelation Biosciences, Inc. (NASDAQ:REVB) rose 36.2% to $1.12 in pre-market trading. Revelation Biosciences recently announced a $4 million public offering.
  • Eyenovia, Inc. (NASDAQ:EYEN) jumped 31.4% to $2.19 in pre-market trading. Eyenovia recently provided an update on its merger with Betaliq and reported better-than-expected first-quarter EPS results.
  • Northern Dynasty Minerals Ltd. (NYSE:NAK) surged 25.2% to $1.44 in pre-market trading. Northern Dynasty Minerals received payment of $12 million representing the third tranche investment under the company's royalty agreement dated July 26, 2022.
  • Basel Medical Group Ltd (NASDAQ:BMGL) gained 24% to $4.86 in pre-market trading after falling 35% on Monday.
  • MoonLake Immunotherapeutics (NASDAQ:MLTX) climbed 21.1% to $49.84 in pre-market trading following reports that Merck held talks to acquire the Swiss biotech company for over $3 billion.
  • Agenus Inc. (NASDAQ:AGEN) rose 18.4% to $4.89 in pre-market trading after jumping 20% on Monday.
  • BioNTech SE (NASDAQ:BNTX) gained 8.4% to $122.62 in pre-market trading. BioNTech shares jumped 18% on Monday after the company entered into an agreement with Bristol Myers Squibb to advance bispecific antibody BNT327 for solid tumors.

Losers

  • Brand Engagement Network, Inc. (NASDAQ:BNAI) shares dipped 16% to $0.4119 in pre-market trading after jumping over 75% on Monday.
  • CleanCore Solutions, Inc. (NYSE:ZONE) shares fell 17.6% to $2.39 in pre-market trading after gaining around 32% on Monday.
  • PS International Group Ltd. (NASDAQ:PSIG) fell 16.7% to $0.30 in pre-market trading.
  • ModivCare Inc.  (NASDAQ:MODV) fell 15% to $1.87 in pre-market trading after jumping 96% on Monday.
  • AgEagle Aerial Systems, Inc. (NYSE:UAVS) shares tumbled 14.3% to $1.08 in pre-market trading after jumping 63% on Monday.
  • Volato Group, Inc. (NYSE:SOAR) declined 14.2% to $2.25 in pre-market trading after gaining 27% on Monday.
  • Mereo BioPharma Group plc (NASDAQ:MREO) fell 5.9% to $2.40 in pre-market trading after jumping over 18% on Monday.
  • Bumble Inc. (NYSE:BMBL) fell 5.8% to $5.41 in today's pre-market trading.
  • Pearson plc (NYSE:PSO) dipped 5% to $15.24 in pre-market trading.
  • GCL Global Holdings Ltd (NASDAQ:GCL) shares fell 4.8% to $2.40 in pre-market trading.

Now Read This:

Photo via Shutterstock

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.